Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragaloside IV Mitigated Diabetic Nephropathy by Restructuring Intestinal Microflora and Ferroptosis
Xin Lyu, Tingting Zhang, Zhen Ye, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 6
Closed Access | Times Cited: 12

Showing 12 citing articles:

Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway
Liu Li, Junju Zou, Hui Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117008-117008
Open Access | Times Cited: 8
Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease
Jun Liu, Jing Ren, Linlan Zhou, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118517-118517
Closed Access | Times Cited: 4
A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells
Jun Liu, Kang Yang, Linlan Zhou, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112794-112794
Closed Access | Times Cited: 4
The gut–kidney axis is regulated by astragaloside IV to inhibit cyclosporine A-induced nephrotoxicity
Cong Han, Ranran Gao, Le Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Tangshenning Formula Alleviates Tubular Injury in Diabetic Kidney Disease via the Sestrin2/AMPK/PGC-1α Axis: Restoration of Mitochondrial Function and Inhibition of Ferroptosis
Xiaomeng Shan, Cong Lu, Chun‐Wei Chen, et al.
Journal of Ethnopharmacology (2025) Vol. 345, pp. 119579-119579
Closed Access
Discovery of the pharmacodynamic material basis of Danggui Buxue Decoction in the treatment of diabetic kidney disease based on lipidomics regulation
Xu Wang, Jing Liu, Tingting Liu, et al.
Phytomedicine (2025), pp. 156643-156643
Closed Access
Iron Metabolism and Ferroptosis in Diabetic Kidney Disease
Fangxin Mu, Ping Luo, Yuexin Zhu, et al.
Cell Biochemistry and Function (2025) Vol. 43, Iss. 4
Closed Access
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN
J. Liu, Min Guo, Xiaobin Yuan, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 4
Open Access
Suppression of ferroptosis through the SLC7A11/glutathione/glutathione peroxidase 4 axis contributes to the therapeutic action of the Tangshenning formula on diabetic renal tubular injury
Xiaomeng Shan, Chun‐Wei Chen, D H Zou, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Research Progress on the Association Between Gut Microbiota and Respiratory System Diseases
Jing Liu, Ruilin Sun
Proceedings of Anticancer Research (2024) Vol. 8, Iss. 3, pp. 68-73
Open Access
Dysregulation of lipid metabolism in chronic kidney disease and the role of natural products
Yang-Yi Jiang, Xiaoli Jiang, Haining Yu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 398, Iss. 1, pp. 261-278
Closed Access
Astragaloside IV Protects against Diabetic Nephropathy by Inhibiting FUNDC1‐Dependent Mitochondria‐Associated Endoplasmic Reticulum Membranes
Zeng Zhang, Yanyan Wang, Fengzhu Zhou, et al.
Journal of Food Biochemistry (2024) Vol. 2024, Iss. 1
Open Access
Page 1

Scroll to top